Fig. 2From: Implications of cardiac markers in risk-stratification and management for COVID-19 patientsSerum cardiac markers drastically elevated in severe/critical patients during the first week. Levels of 12 multiple organ dysfunction indicators in mild/moderate (M) and severe/critical (S) groups during the first week of hospitalization. The difference of each indicator between the two groups is significant (two-sided Wilcoxon test, P < 0.001)Back to article page